STOCK TITAN

Nuvalent (NUVL) CFO sells 11,430 shares and exercises options under plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nuvalent, Inc. Chief Financial Officer Alexandra Balcom exercised stock options and sold shares of Class A Common Stock. She exercised options to acquire 6,046 shares at $18.93 per share and 5,384 shares at $6.89 per share, then sold 11,430 shares in an open-market transaction at a weighted average price of $123.58 per share. These trades were executed under a Rule 10b5-1 trading plan adopted on December 23, 2025. Following the sale, she directly holds 85,533 shares of Class A Common Stock and retains stock options covering 22,933 and 8,016 shares with exercise prices of $18.93 and $6.89, respectively.

Positive

  • None.

Negative

  • None.
Insider Balcom Alexandra
Role Chief Financial Officer
Sold 11,430 shs ($1.41M)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 5,384 $0.00 --
Exercise Stock Option (Right to Buy) 6,046 $0.00 --
Exercise Class A Common Stock 5,384 $6.89 $37K
Exercise Class A Common Stock 6,046 $18.93 $114K
Sale Class A Common Stock 11,430 $123.58 $1.41M
Holdings After Transaction: Stock Option (Right to Buy) — 8,016 shares (Direct, null); Class A Common Stock — 90,917 shares (Direct, null)
Footnotes (1)
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.51 to $123.62, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price. The shares underlying this option are fully vested.
Shares sold 11,430 shares Class A Common Stock open-market sale on July 1, 2026
Sale price $123.58 per share Weighted average sale price, trades between $123.51 and $123.62
Shares held after sale 85,533 shares Direct Class A Common Stock ownership following transactions
Options exercised 6,046 shares at $18.93 Stock option exercise into Class A Common Stock
Options exercised 5,384 shares at $6.89 Second stock option exercise into Class A Common Stock
Remaining option balance 22,933 shares at $18.93 Stock Option (Right to Buy), expires January 4, 2032
Remaining option balance 8,016 shares at $6.89 Stock Option (Right to Buy), expires April 29, 2031
Rule 10b5-1 trading plan regulatory
"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.51 to $123.62, inclusive."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with underlying Class A Common Stock and specified exercise prices."
Class A Common Stock financial
"Transactions involved Class A Common Stock, including open-market sale and shares underlying exercised options."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Exercise or conversion of derivative security financial
"Transaction code M described as Exercise or conversion of derivative security for the stock options."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Balcom Alexandra

(Last)(First)(Middle)
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR

(Street)
CAMBRIDGE MASSACHUSETTS 02142

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock07/01/2026M(1)5,384A$6.8990,917D
Class A Common Stock07/01/2026M(1)6,046A$18.9396,963D
Class A Common Stock07/01/2026S(1)11,430D$123.58(2)85,533D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$6.8907/01/2026M(1)5,384 (3)04/29/2031Class A Common Stock5,384$0.008,016D
Stock Option (Right to Buy)$18.9307/01/2026M(1)6,046 (3)01/04/2032Class A Common Stock6,046$0.0022,933D
Explanation of Responses:
1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.51 to $123.62, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
3. The shares underlying this option are fully vested.
/s/ Nathan N. McConarty, attorney-in-fact07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Nuvalent (NUVL) report for CFO Alexandra Balcom?

Nuvalent reported that CFO Alexandra Balcom exercised stock options to acquire 11,430 Class A shares and sold 11,430 shares in an open-market transaction. The sale used a weighted average price of $123.58 per share and was conducted under a Rule 10b5-1 trading plan.

How many Nuvalent (NUVL) shares did the CFO sell and at what price?

The CFO sold 11,430 shares of Nuvalent Class A Common Stock at a weighted average price of $123.58 per share. The shares were sold in multiple trades between $123.51 and $123.62, according to the filing’s detailed pricing disclosure.

What stock options did the Nuvalent (NUVL) CFO exercise in this Form 4?

The CFO exercised options for 6,046 shares at an exercise price of $18.93 and 5,384 shares at $6.89. These options were fully vested, resulting in 11,430 newly acquired Class A shares before the subsequent open-market sale reported.

How many Nuvalent (NUVL) shares does the CFO hold after these transactions?

After the reported transactions, the CFO directly holds 85,533 shares of Nuvalent Class A Common Stock. This figure reflects her position following both the option exercises and the sale of 11,430 shares disclosed in the Form 4 filing.

Were the Nuvalent (NUVL) CFO share sales made under a Rule 10b5-1 plan?

Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted on December 23, 2025. Such pre-arranged plans allow executives to systematically sell shares according to preset instructions, reducing discretion over trade timing.

What stock options does the Nuvalent (NUVL) CFO retain after these transactions?

After the exercises, the CFO retains stock options for 22,933 shares at a $18.93 exercise price expiring January 4, 2032, and 8,016 shares at a $6.89 exercise price expiring April 29, 2031, as reported for the remaining option holdings.